Most material SEC filings — July 16, 2026

Baker Hughes Company merged with Tango Merger Sub, Inc. into Chart Industries, Inc. on July 16, 2026, with Chart Industries surviving as the acquired entity. The merger agreement was dated July 28, 2025. No financial terms, purchase price, or material deal conditions are disclosed in this certificate of merger filing—only the corporate structure and amended bylaws of the surviving company are documented.

Eli Lilly and Company has agreed to acquire AtaiBeckley Inc. via merger with subsidiary Albali Acquisition Corporation. Merger consideration: $6.75 per share in cash at closing plus one contingent value right (CVR) per share representing potential milestone payments if achieved post-closing. AtaiBeckley shareholders will receive no guaranteed upside beyond $6.75; CVR payments are expressly not guaranteed and Parent makes no commitment to achieve milestones. Deal dated July 15, 2026; Company Board unanimously approved and supports the transaction.

On May 5, 2025, Sunoco LP announced a definitive agreement to acquire all Parkland shares via cash and equity for ~$12.5B (including assumed debt). Shareholders receive 0.295 SunocoCorp units + $19.80/share, with alternative all-cash ($44) or all-unit (0.536) elections. Transaction expected to close October 31, 2025. For 9M 2025, Parkland reported net earnings of $365M vs. $156M in 9M 2024; Q3 2025 net earnings of $129M vs. $91M in Q3 2024.

On July 13, 2026, Our Bond, Inc. (market cap ~$6.7M) received notice of failure to satisfy continued listing standards and potential delisting. The filing does not specify which exchange, which listing rule was violated, or remediation timeline. This represents a critical threat to the company's public trading status.

On July 10, 2026, Caring Brands issued 443,212 shares of Series A Convertible Preferred Stock (stated value $421,053, purchased at $0.95/share with 5% OID) and warrants to purchase 1,052,632 common shares at $0.40/exercise price to WorldBridge Ventures CBRA LLC for $400,000 cash. Concurrently, insider Brian John sold 150,000 common shares to the company (via CEO Glynn Wilson) for $150,000, funded from the investor proceeds in an integrated transaction. The preferred stock is convertible to common at variable prices subject to anti-dilution protection; warrants expire May 29, 2031. Company must maintain Nasdaq listing, register resale shares, and granted investor additional investment rights up to $4M at 90% of weighted-average price.

As of July 15, 2026, Eightco Holdings (market cap ~$3.8M) disclosed total holdings of approximately $406 million, comprising: $90 million indirect equity exposure to OpenAI (through SPVs), $18 million Beast Industries equity, 283.45 million Worldcoin (WLD) tokens valued at $0.41/token (~$116M), 16,278 ETH, and $148 million in cash/stablecoins. The filing highlights that WLD is now listed on Robinhood and that OpenAI filed a confidential S-1 for potential future IPO. Material changes: WLD token unlock reduction scheduled for July 24, 2026, expected to slow daily issuance by 43% (from 5.1M to 2.9M tokens daily); Eightco claims largest publicly disclosed WLD position at ~8% of circulating supply.

Arbutus received approximately $178M (37.7% of company market value) from Moderna on July 8, 2026 as its share of non-contingent settlement proceeds under a March 3, 2026 patent infringement settlement. Separately, Arbutus terminated the mRESVIA Agreement with Genevant (receiving $1M termination fee) and announced plans to return up to ~$230M (48.7% of market value) to shareholders via buybacks in Q3 2026, contingent on receipt of a dividend from Genevant. Arbutus also filed three international patent suits against Pfizer/BioNTech and awarded CEO Lindsay Androski a bonus equal to 1.5% of the non-contingent Moderna proceeds (~$2.67M).

Jasper Therapeutics completed an all-stock acquisition of Kira Pharmaceuticals and raised $132 million in concurrent preferred stock financing from multiple investors including Affinity Asset Advisors, Ikarian Capital, and Mirador Therapeutics. Kira out-licensed two assets (KP-301 and KP-402) to Mirador for $12 million upfront plus potential milestones. Post-transaction, original Jasper shareholders own 6.68%, Kira shareholders own 49.86%, and new investors own 43.46% on a fully-diluted basis; combined company has cash runway through H2 2028.

Eclipse Parent Acquisitions, LLC (Sponsor Luther King Capital Management Corporation owns 36.36M shares, 78.6% of outstanding) agreed to acquire Distribution Solutions Group, Inc. for $35.00 per share in cash ($1.62B total consideration based on 46.26M shares outstanding). Merger Sub will merge into Company; Company becomes wholly-owned subsidiary of Intermediate (Eclipse subsidiary). Special Committee and Board approved transaction July 15, 2026. Equity financing committed by LKCM Headwater Investments IV, L.P.; Credit Agreement Lenders committed to revolving loans. Transaction subject to stockholder approval (disinterested stockholders vote required under DGCL Section 144) and regulatory approvals including HSR Act.

Forum Markets (Nasdaq: FRMM) closed acquisition of one CFM56-7B aircraft engine from Aero Engine Solutions, Inc. for $11.65 million on July 13, 2026. The engine is already generating revenue under long-term lease to major U.S. airlines with projected double-digit annual returns. Company expects to close acquisition of a second similar engine in coming weeks, bringing total aviation portfolio to five engines. Company scale: ~$2.7M market cap.

On July 10, 2026, Edgewise completed the sale of its sevasemten muscular dystrophy program to Servier Pharmaceuticals for $1.55 billion upfront cash plus up to $1.1 billion in regulatory/commercial milestones (total potential $2.65 billion). The transaction generated an estimated $1.488 billion pretax gain ($1.262 billion after-tax). Post-transaction, Edgewise pivots to a cardiovascular-focused company with pipeline programs EDG-7500, EDG-15400, and EDG-003. The company will provide transition services to Servier at 50% cost reimbursement for at least 18 months.

New Horizon Aircraft Ltd. (NASDAQ: HOVR), a $14.2M market-cap VTOL aircraft developer, reported cash and equivalents of $78.3M as of May 31, 2026, representing 24+ months of runway. The company achieved technical milestones including full-scale Cavorite X7 prototype on track for Q1 2027 testing, secured strategic partnerships with BETA Technologies (flight control computers), RAMPF Composite Solutions (fuselage), and North Aircraft Industries (wing structures), and expanded leadership with Chief Engineer Richard Alexander. Headcount planned to grow from 56 to 100+ employees by summer 2027.

Quantum Cyber's subsidiary Quantum Drones Corporation completed acquisition of a 50,000-sq-ft industrial facility in Bridgeport, Connecticut from Arcade Realty LLC for $2,300,000 on July 15, 2026. This represents the company's strategic shift from technology licensing to vertically integrated defense manufacturing with domestic production capacity. The facility acquisition follows prior announcements in May and June 2026 of manufacturing strategy and a separate asset purchase agreement for installed equipment.

FingerMotion reported Q1 2027 (ended May 31, 2026) revenue of $650,089, down 92% ($7.8M decline) from $8.3M in Q1 2026, driven by a 94% collapse in Telecommunications Products Services revenue ($502,672 vs. $8.3M). Despite the revenue crash, gross profit increased 37% to $208,478 due to lower-margin business mix; the company reported a $2.0M net loss versus $2.008M in Q1 2026. As of May 31, 2026, FingerMotion held $987,391 cash, $4.4M working capital, $13.3M shareholders' equity, and 61.3M shares outstanding.

SHF Holdings (Delaware corp., $3.1M market cap) filed Form S-1/A on July 16, 2026 to permit resale of up to 21,517,377 common shares underlying Series B Warrants exercisable at $0.65/share. Warrants were issued September 30, 2025 to investors under a Securities Purchase Agreement. Legal counsel (Duane Morris LLP) opined the shares will be validly issued and fully paid upon warrant exercise. Auditors (Macias Gini O'Connell and Marcum) consented to inclusion of their reports; the primary auditor's report contains a going-concern qualification.

On July 10, 2026, Nasdaq notified Cycurion (NASDAQ: CYCU) that its stock failed the $1.00 minimum bid price requirement for 31 consecutive business days (May 26–July 9, 2026) and determined the company ineligible for the standard 180-day cure period because it executed a 1-for-30 reverse split on October 27, 2025. Trading suspension was scheduled for July 21, 2026, but the company timely requested a hearing before the Nasdaq Hearings Panel (due July 17) to stay suspension pending appeal. The company claims annual revenue exceeding $28M and states operations remain unaffected.

On July 10, 2026, Polar Power, Inc. authorized and issued 1,945 shares of Series A Convertible Preferred Stock (out of 25,000 authorized) to an unnamed initial holder pursuant to a Securities Purchase Agreement. Each share has a $1,000 stated value, accrues a 10% annual dividend in kind, and is convertible into common stock at a price equal to 90% of the 7-day VWAP (minimum Floor Price = 20% of NASDAQ Minimum Price). The holder gains one board designee seat, voting rights on an as-converted basis (subject to 9.99% beneficial ownership cap), senior liquidation preference, and anti-dilution protections. Conversion is capped at 19.99% of outstanding common stock absent stockholder approval under Nasdaq Rule 5635(d).

On July 12, 2026, eBay and Etsy amended their February 2026 sale agreement. eBay irrevocably waived closing condition challenges for specified representations and covenants, limiting future breach claims to intentional post-amendment actions by Etsy with actual knowledge of materiality. The Business Disruption Fee cap was set at $158M (payable only if deal terminates after July 15, 2026); closing is scheduled for July 30, 2026 or later pending UK CMA approval. Key changes include Lockbox Date of July 17, 2026, SOFR+40bps interest on purchase price from Lockbox to Closing, and new employee cash award carve-outs.

IRIDEX's board alleges that Novel Inspiration International Co., Ltd. (largest shareholder, ~$10M Series B investor in March 2025) and board member Will Moore have orchestrated an undisclosed stealth proxy campaign to remove two independent directors ahead of the 2026 annual meeting, without filing required SEC disclosures. The board contends this violates federal proxy rules (Regulation 14A, Section 13(d)) and Delaware fiduciary duties. Novel's Series B preferred conversion at current stock prices would dilute other shareholders by ~2 million shares (~10% of fully diluted cap), which the board opposes. Company claims operational turnaround: revenue grew 8% YoY to ~$52.6M (2025), operating losses cut 90%, achieved Q4 2025 positive cash flow; $5.6M cash on hand.

Uber Technologies and subsidiary Bidco are acquiring Delivery Hero SE (German-listed food delivery platform) via mandatory takeover offer at minimum €41.50/share. Uber secured €11.5B bridge financing (364-day term) from Morgan Stanley syndicate to fund acquisition consideration, Delivery Hero debt repayment, and transaction costs. Transaction requires regulatory approvals in 6+ jurisdictions (EU, Saudi Arabia, UAE, Jordan, Argentina, South Korea) and closing contingent on 50%+ share acceptance.

Trilogy Metals announced publication of a coordinated federal-state permitting schedule for its 50% stake in the Arctic Project (via Ambler Metals JV with South32). The U.S. Army Corps of Engineers is the lead agency; the schedule targets a Record of Decision in September 2028, approximately 29 months from the April 20, 2026 Clean Water Act Section 404 permit application filing. This represents ~25% efficiency gain over historical 3.6-year baseline and establishes a publicly tracked roadmap with defined milestones (Notice of Intent September 2026, Draft EIS October 2027).

Swift Prime Limited (controlled by Guo Li) subscribed for 5,000,000 Class B common shares of AIOS Tech Inc. at $0.0001 per share, totaling $500 consideration, per agreement dated June 26, 2026. Shares are subject to a 5-year lock-up period. Joint filing agreement executed July 16, 2026 by Guo Li and Swift Prime Limited.

Patriot Financial Partners II, L.P. and Patriot Financial Partners Parallel Fund II, L.P. sold 1,500,000 shares of USCB Financial Holdings Class A common stock to Inversiones Atlantida, SA (a Honduran corporation) on July 15, 2026, at $18.50 per share for an aggregate purchase price of $27,750,000. The Purchased Shares represent 8.2% of outstanding common stock as of April 30, 2026, and are freely tradeable without restrictive legend pursuant to an effective Form S-3 registration statement.

On July 15, 2026, NYSE Regulation notified SRX Global Inc. that it has resolved continued listing deficiencies under Section 1003(a)(i) and (ii) of the NYSE American Company Guide, which had been cited in a prior notice dated October 14, 2025. The company's compliance indicator (.BC) will be removed and it will no longer appear on the Exchange's noncompliant issuers list. No specific dollar amounts, percentages, or operational changes are disclosed in the filing.

Goldenwise Capital Group (6.9% shareholder, ~$2.6M position) demanded board expansion and seats for founder Huakun Ding via amended Schedule 13D; Phunware's board rejected the demands as lacking a credible strategic plan, noting Goldenwise shifted from requesting 3 seats (June 4) to demanding 4 seats (later) to 'at least 3' (July 10). Company highlighted $97.9M cash position (as of March 31, 2026), improved Q1 2026 financials (net loss narrowed to $3.2M from $3.7M YoY; gross margin improved to 70.8% from 52.2%), and questioned Goldenwise's undisclosed derivative positions and prior litigation history.

HBM Healthcare Investments (Cayman) Ltd., holding 18.2M Chemomab ordinary shares (plus 62.8M shares underlying prefunded warrants), entered a shareholder support agreement dated July 6, 2026, to vote all its shares in favor of Scipher Medicine Corporation's acquisition of Chemomab. HBM commits to vote for the merger and related transactions, and against competing proposals, with an irrevocable proxy to Scipher if voting deadlines are missed. HBM also must exercise its prefunded warrants within 70 days and increase beneficial ownership limits to 19.99%.

Inhibrx Biosciences secured a Second Amendment to its Loan and Security Agreement with Oxford Finance LLC (led by Oxford Finance LLC, Oxford Finance Credit Fund II LP, and Oxford Finance Credit Fund III LP) dated July 15, 2026, expanding the total credit facility from $175M drawn to $500M available. The amendment provides $100M in Term C Loans funded immediately and up to $225M in optional Term D Loans (in $50M+ increments at lenders' discretion). Inhibrx issued 21,457 warrants at $93.21/share strike (2% of Term C value) to the lenders.

On 07/14/2026, the reporting person sold 700,000 shares of Angel Oak Mortgage REIT common stock at $8.51 per share in open market transactions, totaling approximately $5.96M. This represents a significant reduction in insider holdings and occurred at a price near current market levels.

On June 30, 2026, Alcoa entered into a definitive agreement to acquire South32 Limited's bauxite, alumina, and aluminum operations (AliGroup) across Australia, Brazil, and South Africa for approximately $4.1 billion upfront plus a contingent value right of up to $750 million. The transaction is expected to unlock synergies and enhance Alcoa's position as a pure-play upstream aluminum company. Q2 2026 results showed record quarterly revenue of $3.966 billion (24% sequential increase), net income of $407 million ($1.53/share), and adjusted net income of $562 million ($2.12/share), with cash balance of $1.4 billion after redeeming $219 million of 2028 Notes.

On 2026-07-10, Avalanche Treasury Corp (total assets ~$2.2M) entered into a material definitive agreement and created a direct financial obligation or off-balance sheet arrangement. The specific counterparty, dollar amount, terms, and nature of the agreement are not disclosed in the available filing header; only Item 1.01 and Item 2.03 triggers are listed without substantive detail.

On 7/15/2026, Cosmos Health Inc. (market cap ~$9.5M) filed an 8-K disclosing material modifications to security holder rights, amendments to articles of incorporation/bylaws, and designation of a new Series B Preferred Stock class. The filing includes a Certificate of Designation but the specific terms—liquidation preferences, conversion rights, dividend rates, share count, and capital raised—are not disclosed in the accessible text provided; those details appear only in the referenced exhibit (EX-3.1) which is not reproduced here.

IQSTEL Inc. formed IQSTEL Operating Holdings Inc. (IOH), a wholly owned Nevada subsidiary, effective July 2, 2026, to create a cleaner financial platform for M&A, institutional financing, and digital services expansion. No change to shareholders, board, management, or NASDAQ listing. H1 2026 preliminary revenue reached $207M (vs. $130M in H1 2025, +59% YoY); pending ULTRANET acquisition (51% stake, ~$130M annual revenue, $4.5M net income, $6M EBITDA) expected Q3 2026 closing would push pro forma annual run rate to ~$560M revenue and ~$9M adjusted EBITDA, with consolidated assets increasing from $44.5M to ~$65.5M post-acquisition.

On April 30, 2026, Bakkt completed acquisition of Distributed Technologies Research Global Ltd (DTR), a fintech software company, for 11,316,775 Bakkt Class A shares (valued at ~$97.5M at $8.62/share on closing date), plus up to 725,592 additional shares upon warrant exercise. DTR is controlled by Akshay Naheta, Bakkt's CEO—a related-party transaction approved by Special Committee. DTR's Q1 2026 financials show €1.3M net loss on €42k revenue; goodwill of €3.7M recognized. Pro forma adjusts for $20.7M identified intangibles (customer relationships, technology, non-competes) with annual amortization of $5.7M.

On 7/14/2026, Baker Brothers Life Sciences L.P. sold 2,838,632 shares at $102.50/share (~$291M), and 667 L.P. sold 261,368 shares at the same price (~$26.8M). Combined sale represents ~3.1M shares (approximately 6.8% of current outstanding, based on holdings shown) at an aggregate value of ~$317.8M. Both are major shareholders with significant prefunded warrants and convertible note positions.

Jasper Therapeutics (Parent) agreed to merge with Kira Pharmaceuticals (Company, a Cayman Islands company) via merger subsidiary Kira Holdco. Jasper will issue 5,587,800 shares of voting common stock (capped at 19.9% of outstanding shares pre-closing) plus up to 4,996,178 convertible preferred shares (convertible at 61:1 ratio) to Kira shareholders and option/SAFE holders. Kira shareholders comprise 27.67M ordinary shares and 3.66M preferred shares outstanding as of signing (July 16, 2026). Deal includes concurrent PIPE investment in Jasper convertible preferred stock and CVR issuance to existing Jasper shareholders. Closing expected within 120 days; shareholder votes required from both companies.

10% owner THRIVENT FINANCIAL FOR LUTHERANS (ARDC) bought 160K shares (~$4.0M) on the open market (50% of holdings). Open-market insider purchase — historically a bullish signal.

Rain Enhancement Technologies Holdco established an at-the-market (ATM) offering on July 16, 2026, through sales agent Needham Company, LLC, authorizing the sale of up to $3,513,524 in Class A common stock ($0.0001 par value). The offering is conducted under a Sales Agreement dated June 30, 2026, and related Form S-3 registration statement. No specific share count or drawdown amounts are disclosed in this legal opinion.

On July 16, 2026, USA Rare Earth, Inc. (USAR) amended its April 19, 2026 merger agreement with SVRE Holdings Ltd. to add a new closing condition (Section 6.1(q)) requiring satisfaction of specified conditions under the Offtake Agreement with a U.S. government-backed counterparty, lapse of SVRE's termination rights, and the agreement remaining in full force and effect. The amendment makes these offtake conditions precedent to USAR's obligation to close the merger. SVRE merger consideration remains 126,849,307 shares plus $300 million cash; offtake long-stop date extended from June 12 to August 14, 2026.

State Street reported Q2 2026 total revenue of $4.048B (+17% YoY), fee revenue $3.188B (+17% YoY), and diluted EPS of $3.65 (+68% YoY). Record AUC/A of $57.9T (+18% YoY) and AUM of $6.3T (+23% YoY) driven by market appreciation and $114B net flows. Management fees surged 29% to $772M on higher valuations; servicing fees up 13% to $1.468B; FX trading +27% (ex-notables) to $494M. Expenses rose 5% to $2.659B. Net income $1.084B (+56% YoY). Pre-tax margin 34.3% (+8.5 pts YoY); ROTCE 25.5% (+8.8 pts). Company announced 10% dividend increase to $0.92/share and new medium-term targets: 35% pre-tax margin, mid-20s% ROTCE.

NextBoat reported record transaction closings and quarterly sales in Q2 2026, with transaction volume growing ~120% year-over-year. The company established a partnership with MarineMax (preferred wholesale partner) and Newcoast (finance/insurance), and expects to reach at or near profitability for Q2 after a Q1 loss due to public-company transition costs. APEX achieved profitability post-acquisition; company headcount grew ~42% YoY; specific dollar amounts and net income figures are not disclosed in this preliminary update.

On July 14, 2026, Rent the Runway held its annual meeting with 93% shareholder participation (31.1M shares). Stockholders approved: (1) a First Amendment increasing authorized shares under the 2021 Incentive Plan by 3,899,439 shares to 10,171,225 total (28.99M for, 1.2M against); (2) elimination of unused Class B common stock (50M shares) and preferred stock (10M shares) authorizations; (3) elimination of supermajority voting, prohibition on written consent, and director liability for corporate opportunity breaches; (4) implementation of board quorum requirement and 40% stockholder special meeting rights; and (5) board designation rights under an Investor Rights Agreement with Nexus (Gateway Runway LLC) and STORY 3 (S3 RR Aggregator LLC). Director Suchi Sastri was appointed to the board as a Class III independent director and joined the Audit Committee, restoring Nasdaq compliance (3 independent audit committee members). The Thirteenth Amended and Restated Certificate of Incorporation was filed July 15, 2026.

Flash Sports Media Holdings (market cap ~$3.1M) announced July 16, 2026 launch of FLASH, a direct-to-consumer mobile app for live cricket streaming, highlights, scores, and fan engagement available on Google Play and Android TV in North America. The app leverages the company's existing production capabilities and Lanka Premier League Season 6 rights through subsidiary IPG to build direct fan relationships and create new revenue streams via sponsorship and subscription.